IP Library Granted Patent US 11,473,142
Granted Patent B2
US 11,473,142 · App. 17/476,712 · Granted Oct 18, 2022

Chemical compositions and uses thereof

Inventors: Joseph M. Beechem (Eugene, OR); Dae Kim (Bellevue, WA); Margaret Hoang (Seattle, WA); Mark Gregory (Boise, ID); Erin Piazza (Edmonds, WA); Denise Zhou (Seattle, WA)
Assignee: NanoString Technologies, Inc.
C12Q1/6876C12Q1/6804C12Q1/686C12Q1/6818C12Q1/6841C12Q1/6848C12Q1/6851C12Q1/6855C12Q1/6858C12Q1/6869C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,473,142
App. No.
17/476,712
Granted
Oct 18, 2022
Kind
B2
Abstract

The present invention relates to, among other things, probes, compositions, methods, and kits for simultaneous, multiplexed detection and quantification of protein and/or nucleic acid expression in a user-defined region of a tissue, user-defined cell, and/or user-defined subcellular structure within a cell that are adaptable for use with existing sequencing technologies.

Claims (18)

1. A method comprising:

a) collecting a plurality of oligonucleotides from a first location of a tissue sample under conditions that release the plurality of oligonucleotides from the first location of the tissue sample;

b) collecting a plurality of oligonucleotides from a second location of the tissue sample under conditions that release the plurality of oligonucleotides from the second location of the tissue sample;

c) synthesizing a first plurality of DNA products by performing a synthesis reaction that uses the plurality of oligonucleotides collected in step (a) as templates and incorporates at least one nucleic acid sequence that identifies the first location of the tissue sample into each of the first plurality of DNA products;

d) synthesizing a second plurality of DNA products by performing a synthesis reaction that uses the plurality of oligonucleotides collected in step (b) as templates and incorporates at least one nucleic acid sequence that identifies the second location of the tissue sample into each of the second plurality of DNA products; and

e) identifying the first plurality of DNA products and the second plurality of DNA products synthesized in step (c) and step (d) by sequencing the first plurality of DNA products and the second plurality of DNA products, thereby spatially detecting the plurality of oligonucleotides collected from the first location of the tissue sample and the plurality of oligonucleotides collected from the second location of the tissue sample.

2. The method of claim 1 , wherein the tissue sample is immobilized onto a microscope slide.

3. The method of claim 2 , wherein the microscope slide comprises a plurality of primers immobilized on the microscope slide.

4. The method of claim 3 , wherein the plurality of primers is immobilized on the microscope slide at their 5′ ends.

5. The method of claim 4 , wherein each of step (c) and step (d) comprises performing a solid-phase amplification reaction, wherein the solid-phase amplification reaction is carried out on the microscope slide using the plurality of primers immobilized on the microscope slide.

6. The method of claim 1 , wherein the sequencing step is performed using a next generation sequencing reaction.

7. The method of claim 1 , further comprises amplifying a library using the first plurality of DNA products and the second plurality of DNA products as templates.

8. The method of claim 1 , wherein the at least one nucleic acid sequence that identifies the first location of the tissue sample comprise at least one unique molecular identifier.

9. The method of claim 1 , wherein the at least one nucleic acid sequence that identifies the second location of the tissue sample comprise at least one unique molecular identifier.

10. The method of claim 1 , wherein the first plurality of DNA products further comprises at least one amplification primer binding site.

11. The method of claim 1 , wherein the second plurality of DNA products further comprises at least one amplification primer binding site.

12. The method of claim 1 , wherein steps (a) and (b) are performed simultaneously.

13. The method of claim 1 , wherein steps (c) and (d) are performed simultaneously.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2024
From: NANOSTRING TECHNOLOGIES, INC.
To: BRUKER SPATIAL BIOLOGY, INC.
Reel/Frame 067664/0509 →
RELEASE OF SECURITY INTEREST Recorded May 16, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: NANOSTRING TECHNOLOGIES, INC.
Reel/Frame 067453/0565 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2024
From: NANOSTRING TECHNOLOGIES, INC.
To: BRUKER SPATIAL BIOLOGY, INC.
Reel/Frame 067932/0109 →
RELEASE OF SECURITY INTEREST Recorded May 16, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: NANOSTRING TECHNOLOGIES, INC.
Reel/Frame 067453/0577 →
SECURITY INTEREST Recorded Feb 8, 2024
From: NANOSTRING TECHNOLOGIES, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 066528/0634 →
SECURITY INTEREST Recorded Nov 7, 2023
From: NANOSTRING TECHNOLOGIES, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065490/0058 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2021
From: BEECHEM, JOSEPH M.; KIM, DAE; HOANG, MARGARET; GREGORY, MARK; PIAZZA, ERIN; ZHOU, DENISE
To: NANOSTRING TECHNOLOGIES, INC.
Reel/Frame 057502/0266 →
Continuity (4)
Continuation 16272487 · Feb 11, 2019
Provisional Application 62771212 · Nov 26, 2018
Provisional Application 62629180 · Feb 12, 2018
Related Publication 20210403999A1 · Dec 30, 2021
Cited By (4)
US 12,435,361 US 12,630,869 US 12,655,473 US 12,655,478